CLINICAL AND LABORATORY FINDINGS IN PATIENTS WITH ALCOHOLIC CIRRHOSIS AND DIABETES MELLITUS AT GASTROENTEROLOGY AND HEPATOLOGY CENTER, BACH MAI HOSPITAL, 2024–2025

Công Long Nguyễn, Thị Nhã Nguyễn, Phương Thảo Bùi

Main Article Content

Abstract

Objective: To investigate the clinical and subclinical characteristics of patients with alcoholic cirrhosis and diabetes. Subjects and Methods: A cross-sectional descriptive study of 68 patients diagnosed with alcoholic cirrhosis and diabetes from August 2024 to May 2025. Results: The average age was 57.13±8.05, and 100% were male. They had a history of alcohol use for over 20 years, and 50% of patients had an AUDIT score > 20 points. Clinical symptoms of liver dysfunction included fatigue, loss of appetite (66.1%); jaundice (45.6%); vomiting, bloody stools (38.2%), ascites (57.4%), and anemia (55.8%). The majority of patients had reduced hemoglobin, platelets, and prothrombin levels. At the time of admission, 55.9% of patients had a blood glucose level ≥ 11.1 mmol/L, while only 1 patient had a blood glucose level < 3.9 mmol/L. The average values of liver enzymes tended to increase: ALT: 81.52±170.39 U/L, AST: 132.4±189.19 U/L, GGT: 471.54±427.07 U/L. Endoscopy images showed mostly esophageal varices, with grade III varices accounting for 58.8%. Regarding complications of cirrhosis, the most common were ascites (70.6%), gastrointestinal bleeding (38.2%); hepatic encephalopathy (19.1%); hepatorenal syndrome (4.4%), and spontaneous bacterial peritonitis (3.0%). Conclusion: Patients with alcoholic cirrhosis and diabetes were mostly hospitalized for hyperglycemia or hypoglycemia accompanied by complications of cirrhosis

Article Details

References

Kumar R. Hepatogenous Diabetes: An Underestimated Problem of Liver Cirrhosis. Indian J Endocrinol Metab. 2018;22(4):552-559. doi: 10.4103/ijem.IJEM_79_18
2. Carr RM, Correnti J. Insulin resistance in clinical and experimental alcoholic liver disease. Annals of the New York Academy of Sciences. 2015; 1353(1):1-20. doi:10.1111/nyas.12787
3. Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH. ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol. 2018;113(2):175-194. doi:10.1038/ajg.2017.469
4. ElSayed NA, Aleppo G, Aroda VR, et al. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes—2023. Diabetes Care. 2023;46 (Supplement_1): S10-S18. doi:10.2337/dc23-S001
5. Phạm Thị Thuỳ. Nhận xét một số đặc điểm lâm sàng và cận lâm sàng ở bệnh nhân xơ gan có đái tháo đường. Luận văn tốt nghiệp chuyên khoa cấp II. Đại học Y Hà Nội. 2004.
6. Ngô Thuỳ Dung. Khảo sát giá trị thang điểm ABIC trong tiên lượng bệnh gan do rượu. https://tapchiyhocvietnam.vn/index.php/vmj/article/view/8559/7576. Published October 2023. Accessed May 21, 2025.
7. Behera BP, Dash M. An observational study of clinical and hematological profile of cirrhosis of liver. Asian J Pharm Clin Res. February 2020:149-152. doi:10.22159/ajpcr.2020.v13i4.36862
8. Phạm Thị Dung. Nghiên cứu nồng độ Homocystein huyết tương ở bệnh nhân xơ gan do rượu. Luận văn tốt nghiệp chuyên khoa cấp II. Học viện Quân Y. 2018.
9. Coman LI, Coman OA, Bădărău IA, Păunescu H, Ciocîrlan M. Association between Liver Cirrhosis and Diabetes Mellitus: A Review on Hepatic Outcomes. JCM. 2021;10(2):262. doi:10. 3390/jcm10020262
10. Nguyễn Thanh Nam, Nguyễn Công Long HVC. Biến chứng xơ gan ở bệnh nhân xơ gan mất bù có đái tháo đường. VMJ. 2023;527(2). doi:10.51298/vmj.v527i2.5848